Jiazhen Jiang

486 total citations
18 papers, 389 citations indexed

About

Jiazhen Jiang is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Jiazhen Jiang has authored 18 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Jiazhen Jiang's work include interferon and immune responses (2 papers), Extracellular vesicles in disease (2 papers) and Drug-Induced Adverse Reactions (2 papers). Jiazhen Jiang is often cited by papers focused on interferon and immune responses (2 papers), Extracellular vesicles in disease (2 papers) and Drug-Induced Adverse Reactions (2 papers). Jiazhen Jiang collaborates with scholars based in China, United States and Taiwan. Jiazhen Jiang's co-authors include Chih‐Yang Wang, Zhengda Sun, Chung-Chieh Chiao, Meng‐Chi Yen, Chaoliang Tang, Yida Hu, Si Shi, Hui‐Ping Hsu, Ming‐Derg Lai and Nam Nhut Phan and has published in prestigious journals such as Environmental Science & Technology, American Journal Of Pathology and Life Sciences.

In The Last Decade

Jiazhen Jiang

18 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiazhen Jiang China 9 214 74 67 49 40 18 389
Lander Egaña-Gorroño United States 11 143 0.7× 63 0.9× 19 0.3× 49 1.0× 11 0.3× 17 458
Hongjie Li China 15 213 1.0× 35 0.5× 74 1.1× 198 4.0× 33 0.8× 39 589
Yingchao Hu China 13 345 1.6× 83 1.1× 29 0.4× 66 1.3× 29 0.7× 22 515
Emily C. Britt United States 7 304 1.4× 127 1.7× 32 0.5× 68 1.4× 32 0.8× 10 652
Ramani Soundararajan United States 14 261 1.2× 49 0.7× 131 2.0× 64 1.3× 20 0.5× 26 492
Lisa Philp Australia 11 130 0.6× 79 1.1× 52 0.8× 87 1.8× 38 0.9× 15 437
Takehiro Hirano Japan 9 227 1.1× 72 1.0× 39 0.6× 182 3.7× 73 1.8× 22 488
Sarah Rosli Australia 13 302 1.4× 29 0.4× 44 0.7× 67 1.4× 16 0.4× 19 513
Geun Bae Rha United States 10 292 1.4× 58 0.8× 9 0.1× 77 1.6× 37 0.9× 11 629
Ramesh R. Kaini United States 9 226 1.1× 66 0.9× 24 0.4× 108 2.2× 15 0.4× 14 501

Countries citing papers authored by Jiazhen Jiang

Since Specialization
Citations

This map shows the geographic impact of Jiazhen Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiazhen Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiazhen Jiang more than expected).

Fields of papers citing papers by Jiazhen Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiazhen Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiazhen Jiang. The network helps show where Jiazhen Jiang may publish in the future.

Co-authorship network of co-authors of Jiazhen Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiazhen Jiang. A scholar is included among the top collaborators of Jiazhen Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiazhen Jiang. Jiazhen Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zeng, Yi, et al.. (2025). Safety issues of Donepezil combined with Memantine in Alzheimer’s disease population: real-world pharmacovigilance. Expert Opinion on Drug Safety. 1–11. 2 indexed citations
3.
Zeng, Yi, et al.. (2025). Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance. Expert Opinion on Drug Safety. 1–15. 2 indexed citations
4.
Jiang, Jiazhen, et al.. (2024). Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System. Expert Opinion on Drug Safety. 25(1). 143–155. 4 indexed citations
5.
Yeh, I‐Jeng, Ching‐Chung Ko, Hoang Dang Khoa Ta, et al.. (2024). A comparative analysis of Marburg virus-infected bat and human models from public high-throughput sequencing data. International Journal of Medical Sciences. 22(1). 1–16. 3 indexed citations
6.
Jiang, Jiazhen, et al.. (2024). Deferiprone protects photoreceptors by inhibiting ferroptosis after experimental retinal detachment. Experimental Eye Research. 250. 110156–110156. 5 indexed citations
7.
Wang, Li‐Song, et al.. (2024). CDR1as Deficiency Prevents Photoreceptor Degeneration by Regulating miR-7a-5p/α-syn/Parthanatos Pathway in Retinal Detachment. American Journal Of Pathology. 195(2). 293–305. 1 indexed citations
8.
Anuraga, Gangga, Hoang Dang Khoa Ta, Jiazhen Jiang, et al.. (2023). Integrated bioinformatics approaches to investigate alterations in transcriptomic profiles of monkeypox infected human cell line model. Journal of Infection and Public Health. 17(1). 60–69. 10 indexed citations
9.
Wang, Chin‐Chou, Wan‐Jou Shen, Gangga Anuraga, et al.. (2022). Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer. Journal of Personalized Medicine. 12(12). 1947–1947. 6 indexed citations
10.
Yeh, I‐Jeng, Chung-Che Wu, Chung-Chieh Chiao, et al.. (2022). Comparison of Transcriptomic Signatures between Monkeypox-Infected Monkey and Human Cell Lines. Journal of Immunology Research. 2022. 1–17. 37 indexed citations
11.
Tang, Chaoliang, Yida Hu, Haiyan Lyu, et al.. (2020). Neuroprotective effects of 1‐O‐hexyl‐2,3,5‐trimethylhydroquinone on ischaemia/reperfusion‐induced neuronal injury by activating the Nrf2/HO‐1 pathway. Journal of Cellular and Molecular Medicine. 24(18). 10468–10477. 12 indexed citations
12.
Wang, Chih‐Yang, Chung-Chieh Chiao, Nam Nhut Phan, et al.. (2020). Gene signatures and potential therapeutic targets of amino acid metabolism in estrogen receptor-positive breast cancer.. PubMed. 10(1). 95–113. 95 indexed citations
13.
Hu, Yida, Chaoliang Tang, Jiazhen Jiang, et al.. (2020). Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca2+-STIM1/Orai1 Signaling. Current Medical Science. 40(4). 699–707. 8 indexed citations
14.
Tang, Chaoliang, Yida Hu, Jie Gao, et al.. (2020). Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sciences. 257. 118004–118004. 56 indexed citations
15.
Yeh, I‐Jeng, Nam Nhut Phan, Yen‐Hung Wu, et al.. (2020). Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models. Infection Genetics and Evolution. 85. 104438–104438. 50 indexed citations
16.
Phan, Nam Nhut, Shirui Liu, Chih‐Yang Wang, et al.. (2020). Overexpressed gene signature of EPH receptor A/B family in cancer patients-comprehensive analyses from the public high-throughput database.. PubMed. 13(5). 1220–1242. 21 indexed citations
18.
Li, Jiazheng, Jiazhen Jiang, Lei Huang, et al.. (2016). Propofol reduces liver dysfunction caused by tumor necrosis factor-α production in Kupffer cells. Journal of Anesthesia. 30(3). 420–426. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026